Ju Fu Tang Biotech holds annual shareholder meeting

• Ju Fu Tang Biotech Holdings held its annual general meeting on Sept. 10, 2026.
• Shareholders adopted the audited consolidated financial statements for the year ended March 31, 2026, alongside the directors’ and auditors’ reports.
• Infinity CPA Limited was reappointed as auditor, with the board authorized to set its remuneration.
• A general mandate was granted to issue additional shares up to 20% of issued share capital; approval does not itself issue shares.
• A general mandate was granted to repurchase up to 10% of issued shares, with authority to extend the issue mandate by repurchased shares; no buyback is confirmed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ju Fu Tang Biotech Holdings Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260910-12328056), on September 10, 2026, and is solely responsible for the information contained therein.